Cargando…

Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis

Stricter control of risk factors has been pursued as a compelling strategy to mitigate cardiovascular events (CVE) in type 2 diabetes (T2D) individuals. However, the achievement rate of the recommended goals has remained low in clinical practice. This study investigated the 2019 ESC guideline recomm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barreto, Joaquim, Luchiari, Beatriz, Wolf, Vaneza L. W., Bonilha, Isabella, Bovi, Ticiane G., Assato, Barbara S., Breder, Ikaro, Kimura-Medorima, Sheila T., Munhoz, Daniel B., Quinaglia, Thiago, Coelho-Filho, Otavio R., Carvalho, Luiz Sergio F., Nadruz, Wilson, Sposito, Andrei C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024646/ https://www.ncbi.nlm.nih.gov/pubmed/35453862 http://dx.doi.org/10.3390/diagnostics12040814

Ejemplares similares

Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial
por: Sposito, Andrei C., et al.
Publicado: (2022)

Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus
por: Wolf, Vaneza Lira W., et al.
Publicado: (2021)

Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial
por: Breder, Ikaro, et al.
Publicado: (2020)

Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial
por: Cintra, Riobaldo M. R., et al.
Publicado: (2019)

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial
por: Sposito, Andrei C., et al.
Publicado: (2021)

Very low HDL levels: clinical assessment and management
por: Bonilha, Isabella, et al.
Publicado: (2023)

The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives
por: Barreto, Joaquim, et al.
Publicado: (2023)

Coronavirus disease-19: The multi-level, multi-faceted vasculopathy
por: Quinaglia, Thiago, et al.
Publicado: (2021)

Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design
por: Barreto, Joaquim, et al.
Publicado: (2023)

The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus
por: Bonilha, Isabella, et al.
Publicado: (2021)

Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model
por: Nogueira, Ana Claudia Cavalcante, et al.
Publicado: (2023)

Cardiac Sympathetic Activity and the Neuro-Humoral Theory on Heart Failure with Reduced Ejection Fraction: Have We Learned Enough?
por: Silva, Thiago Quinaglia A. C., et al.
Publicado: (2018)

P-wave duration is a predictor for long-term mortality in post-CABG patients
por: Kimura-Medorima, Sheila Tatsumi, et al.
Publicado: (2018)

Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy
por: de Souza, Thiago Ferreira, et al.
Publicado: (2021)

Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis
por: de Carvalho, Luiz Sergio Fernandes, et al.
Publicado: (2022)

O Impacto da Educação na Mortalidade por Todas as Causas após Infarto do Miocárdio com Supradesnivelamento do Segmento ST (IAMCSST): Resultados do Brasília Heart Study
por: Barreto, Joaquim, et al.
Publicado: (2021)

Aspirin in primary prevention and the risk of heart failure: a systematic review and meta‐analysis of controlled trials
por: de Oliveira, Ana Beatrice Magalhães, et al.
Publicado: (2022)

Omega-3 intake is associated with attenuated inflammatory response and cardiac remodeling after myocardial infarction
por: Campos-Staffico, Alessandra M., et al.
Publicado: (2019)

Cystatin C as a Candidate Biomarker of Cardiovascular Outcomes: Too Near, but too Far from Reality
por: de Carvalho, Luiz Sérgio F., et al.
Publicado: (2018)

Noninvasive imaging assessment of rehabilitation therapy in heart failure with preserved and reduced left ventricular ejection fraction (IMAGING-REHAB-HF): design and rationale
por: Cardoso, Fernando Bianchini, et al.
Publicado: (2019)

Diffuse Myocardial Fibrosis and Cardiomyocyte Diameter Are Associated With Heart Failure Symptoms in Chagas Cardiomyopathy
por: Nardi Gemme, Cristiane, et al.
Publicado: (2022)

Characterization of peri-infarct zone by CMR is a robust predictor of major adverse events and is strongly associated with systemic inflammatory response post-myocardial infarction
por: Sposito, Andrei, et al.
Publicado: (2011)

Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications
por: Bonilha, Isabella, et al.
Publicado: (2021)

Statin Short-term Inhibition of Insulin Sensitivity and Secretion During Acute Phase of ST-Elevation Myocardial Infarction
por: Sposito, Andrei C., et al.
Publicado: (2019)

Pre-clinical left ventricular myocardial remodeling in patients with Friedreich’s ataxia: A cardiac MRI study
por: Takazaki, Karen A. G., et al.
Publicado: (2021)

Prognostic role of renal replacement therapy among hospitalized patients with heart failure in the Brazilian national public health system
por: Coy-Canguçu, Andréa, et al.
Publicado: (2023)

Eficácia da Hidratação Oral na Prevenção da Nefropatia Induzida por Contraste em Indivíduos Submetidos a Intervenções Coronárias Eletivas
por: Pioli, Mariana Rodrigues, et al.
Publicado: (2023)

Quality of Intra-Hospital Nutritional Counseling in Patients with STEMI in the Public and Private Health Networks of Sergipe: The VICTIM Register
por: Lima, Ticiane Clair Remacre Munareto, et al.
Publicado: (2019)

Influência da Localização Geográfica no Acesso às Terapias de Reperfusão e Mortalidade de Pacientes com IAMcSST em Sergipe: Registro VICTIM
por: Oliveira, Jeferson Cunha, et al.
Publicado: (2021)

Diabetic and non-diabetic patients in the intensive care unit: morbidity and mortality
por: Barros, Antonio Carlos, et al.
Publicado: (2015)

Disparities In The Use Of Drug-eluting Stents For Diabetic Patients With ST-elevation Acute Myocardial Infarction Assisted In the Public versus Private Network - VICTIM Register
por: Oliveira, Jussiely Cunha, et al.
Publicado: (2019)

Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19
por: Carmo, Helison Rafael P., et al.
Publicado: (2023)

Low-density lipoprotein cholesterol and radiotherapy-induced carotid atherosclerosis in subjects with head and neck cancer
por: Pereira, Eduardo B, et al.
Publicado: (2014)

ST-elevation myocardial infarction risk in the very elderly
por: Campos, Alessandra M., et al.
Publicado: (2016)

Relationship Between Circulating MicroRNAs and Left Ventricular Hypertrophy in Hypertensive Patients
por: Lopes, Elisangela C. P., et al.
Publicado: (2022)

Takotsubo Syndrome: Special Attention to Women’s Health
por: Silva, Thiago Quinaglia Araújo Costa, et al.
Publicado: (2022)

CSII treatment as an option in high-risk pregnant patients with type 1 diabetes
por: Breder, Íkaro Soares Santos, et al.
Publicado: (2015)

Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables
por: Toledo, Camila Cristiane, et al.
Publicado: (2021)

Association of Circulating miR-145-5p and miR-let7c and Atherosclerotic Plaques in Hypertensive Patients
por: Minin, Eduarda O. Z., et al.
Publicado: (2021)

Disparities in Access and Mortality of Patients With ST‐Segment–Elevation Myocardial Infarction Using the Brazilian Public Healthcare System: VICTIM Register
por: Oliveira, Jussiely Cunha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7g12kbdg8qpse0viktj5gjtpsf